Discover Top 50 Companies in Stem Cell Therapy: Global Market Overview, Benefits, Share, Market Size, Revenue Report (2024-2035).
RELEASE DATE: Jul 2025 Author: Spherical InsightsRequest Free Sample Speak to Analyst
Description
According to a research report published by Spherical Insights & Consulting, The Global Stem Cell Therapy Market Size is Projected to Grow from USD 401 Million in 2024 to USD 1929 Million by 2035, at a CAGR of 17.01 % during the forecast period 2025–2035. The stem cell therapy market offers future opportunities in regenerative medicine, personalized treatment for chronic diseases, neurodegenerative disorders, organ repair, and oncology, driven by advancing research, favorable regulations, and rising clinical trial success.
Introduction
The stem cell therapy market refers to the segment of regenerative medicine focused on using stem cells to repair, replace, or regenerate damaged tissues, organs, or cells in the human body. This therapy leverages the unique ability of stem cells to differentiate into various specialized cell types, offering promising treatment solutions for conditions such as cancer, autoimmune diseases, orthopedic injuries, and neurological disorders. Key driving factors include the rising prevalence of chronic diseases, increased investment in stem cell research, expanding clinical applications, technological advancements in cell harvesting and preservation, supportive regulatory frameworks, and growing awareness of personalized medicine and regenerative treatment options.
Navigate Future Markets with Confidence: Insights from Spherical Insights LLP
The insights presented in this blog are derived from comprehensive market research conducted by Spherical Insights LLP, a trusted advisory partner to leading global enterprises. Backed by in-depth data analysis, expert forecasting, and industry-specific intelligence, our reports empower decision-makers to identify strategic growth opportunities in fast-evolving sectors. Clients seeking detailed market segmentation, competitive landscapes, regional outlooks, and future investment trends will find immense value in the full report. By leveraging our research, businesses can make informed decisions, gain a competitive edge, and stay ahead in the transition toward sustainable and profitable solutions.
Unlock exclusive market insights—Download the Brochure now and dive deeper into the future of the stem cell therapy market.
Stem Cell Therapy Market Size & Statistics
The Market for Stem Cell Therapy was estimated to be Worth USD 401 Million in 2024.
The Market is Going to expand at a CAGR of 17.01 % between 2025 and 2035.
The Global Stem Cell Therapy Market Size is anticipated to Reach USD 1929 Million by 2035.
North America is expected to generate the highest demand during the forecast period in the stem cell therapy market.
Asia Pacific is expected to grow the fastest during the forecast period in The Stem Cell Therapy Market.
Regional growth and demand
Asia Pacific is expected to grow the fastest during the forecast period in the stem cell therapy market. The Asia-Pacific region is projected to experience the highest CAGR from 2025 to 2035 due to shifts in healthcare infrastructure, the growth of major corporations, and an increase in musculoskeletal conditions
North America is expected to generate the highest demand during the forecast period in the stem cell therapy market. North America is projected to be the biggest market. This region is leading because of increased R&D, a robust biotechnology sector, and the presence of important companies. Furthermore, an increase in government measures.
Top Key Drivers & Stem Cell Therapy Trends
- Rising Prevalence of Chronic and Degenerative Diseases
One of the key drivers of the stem cell therapy market is the increasing incidence of chronic and degenerative diseases such as Parkinson’s, Alzheimer’s, cardiovascular conditions, and osteoarthritis. These disorders often lack effective long-term treatment options, making regenerative solutions highly attractive. Stem cell therapy provides potential for cellular regeneration and functional recovery, offering hope to patients with previously untreatable conditions. As aging populations rise globally, especially in developed and emerging economies, the demand for innovative therapeutic approaches is accelerating. Governments and private institutions are also investing more in stem cell research to address the growing healthcare burden.
- Technological Advancements and Expanded Clinical Applications
Rapid advancements in biotechnology, cell culture, and genomic editing have significantly enhanced the safety, scalability, and efficacy of stem cell therapies. Technologies such as CRISPR-Cas9, 3D bioprinting, and iPSC (induced pluripotent stem cell) development are opening new avenues for disease modeling, drug screening, and personalized treatment. Furthermore, stem cell therapies are expanding beyond traditional areas like orthopedics and hematology into oncology, dermatology, and neurology. The growing number of clinical trials and regulatory approvals for new therapies is fueling market confidence and adoption. These innovations are not only improving outcomes but also attracting more investment into the regenerative medicine ecosystem.
Top 5 Cell Therapy Startups Impacting the Pharma Sector
- Rexgenero – Autologous Therapy
Cell therapy entails the injection of living cells to restore a patient’s damaged or depleted cells for addressing specific health issues. Autologous therapy permits the handling of a patient’s cells or tissues externally and facilitates their later re-admission into the body. Because autologous therapy utilizes the patient's own cells, there is no possibility of an adverse immune reaction. Rexgenero is a UK-based startup focused on creating cell therapies for unaddressed medical requirements. The primary product REX-001 is an autologous suspension of bone marrow-derived cells that is high in white blood cells. The treatment aids in addressing chronic limb ischemia (CLI) by supplying immune and progenitor cells directly to the affected vessels in the lower leg. This approach has clinical validation and is presently in phase 3 trials.
- Allogene Therapeutics – Allotransplantation
Although autologous therapies are tailored for individual patients, large-scale production is essential for off-the-shelf treatments. Allotransplantation or allogeneic treatment entails utilizing extensively produced, and thus easily accessible, cells from non-related donors. This therapy allows treatment for elderly patients, who frequently have comorbidities, using cells from young, healthy donors. Yet, these treatments must reduce the likelihood of an immune reaction to be effective. Allogene Therapeutics is a company in the US focused on creating allogeneic treatments for cancer. The approach utilizes cells from healthy donors to provide allogeneic chimeric antigen receptor T cell (AlloCAR-T) treatment. The approach removes T cell receptors (TCR) from donor cells to avoid graft vs. host disease (GvHD). The startup’s development includes treatments for blood cancers and solid tumors, along with a lymphodepleting agent.
- BlueRock Therapeutics – Engineered Cell Therapy
Progress in cell therapy has coincided with the development of novel and enhanced gene-editing methods. Prior to reintroduction, accurate genetic alterations in cells derived from patients facilitate treatments that remove a detrimental gene or add or enhance a beneficial one. Startups currently provide engineered cell treatments for cancers, blood disorders, and skin conditions, among other ailments. The startup BlueRock Therapeutics, located in the US, focuses on engineered cell therapy for regenerative medicine. The startup employs exclusive bioprocessing and manufacturing methods to generate master cell banks from cells of healthy donors. These can be adapted using differentiation techniques to create specialized cell lines for uses in neurology, cardiology, and immunology. The startup's offerings substitute cells, revive function, and reverse disease conditions.
- TreeFrog Therapeutics – Stem Cell Therapy
The field of stem cell research has made considerable progress in recent years. This has unlocked therapeutic uses for various medical issues, including diabetes, neurodegenerative disorders, heart diseases, and aging. Using induced pluripotent stem cells (iPSCs), pharmaceutical startups and firms can now convert even specialized cell lines into different cell lines. This requires solutions that replicate the extracellular environment to encourage the growth and proper differentiation of stem cells in bioreactors. French company TreeFrog Therapeutics provides a platform for stem cell therapy. C-Stem facilitates the 3D culture of stem cells for large-scale cell production for therapeutic purposes. The system employs microfluidics and a droplet generation mechanism to enclose pluripotent stem cells inside tiny alginate capsules. Activation of the stem cells promotes the differentiation of specific cell lines inside the bioreactor. The breakdown of the alginate layer produces induced pluripotent stem cells. The approach is facilitating a series of treatments for Huntington’s disease, heart failure, and diabetes.
- Membio – Synthetic Blood
Blood transfusion is a recognized cell therapy with applications for various health issues, including anemia, severe injuries, and surgical operations. Nonetheless, blood from donors frequently falls short of meeting the necessity for transfusions. Transfusions may also pose the risk of infections due to improper handling or lack of testing equipment. Synthetic blood, generated without the need for donors, provides a scalable option. Membio, a Canadian startup, utilizes biomanufacturing to create synthetic blood. The startup generates specific cell lines from hematopoietic stem cells that facilitate boundless production in a sustainable and scalable manner. The fully operational red blood cells resemble those created in human bodies but are devoid of pathogens and universally compatible. Synthetic blood has a longer shelf life, which reduces the necessity for multiple transfusions.
Empower your strategic planning:
Stay informed with the latest industry insights and market trends to identify new opportunities and drive growth in the stem cell therapy market. To explore more in-depth trends, insights, and forecasts, please refer to our detailed report.
Top 18 Companies Leading the Stem Cell Therapy Market
- Advanced Cell Technology Inc.
- STEMCELL Technologies Inc.
- Cellular Engineering Technologies Inc.
- CellGenix GmbH
- PromoCell GmbH
- Kite Pharma
- Lonza
- Cellartis AB
- Angel Biotechnology
- Brainstorm Cell Therapeutics
- Celgene Corporation
- Osiris Therapeutics
- Genea Biocells
- Bioheart Inc.
- Waisman Biomanufacturing
- Tigenix
- Caladrius Biosciences
- Gamida Cell
1. Advanced Cell Technology Inc.
Headquarters: Marlborough, Massachusetts, USA
Advanced Cell Technology Inc. (now part of Astellas Pharma) was a pioneering biotechnology company specializing in the development of cellular therapies using stem cells, particularly human embryonic stem cells (hESCs). The company focused on regenerative medicine applications in ophthalmology, including therapies for macular degeneration and Stargardt's disease. It was among the first to receive approval for clinical trials using hESCs in humans. With a strong emphasis on scientific innovation and ethical research practices, Advanced Cell Technology contributed significantly to early stem cell advancements. The company was acquired by Astellas Pharma in 2016 to enhance its regenerative medicine pipeline.
2. STEMCELL Technologies Inc.
Headquarters: Vancouver, British Columbia, Canada
STEMCELL Technologies Inc. is a leading biotechnology company specializing in the development and manufacturing of cell culture media, reagents, and tools for life sciences research, particularly in the field of stem cells and regenerative medicine. The company supports researchers working with pluripotent stem cells, hematopoietic stem cells, mesenchymal stem cells, and neural stem cells. Its flagship products include specialized culture media like mTeSR™1 for human embryonic and induced pluripotent stem cells. STEMCELL Technologies is renowned for its rigorous quality standards, scientific expertise, and training resources, serving researchers in over 70 countries with products that advance discovery and cell-based therapies.
3. Cellular Engineering Technologies Inc. (CET)
Headquarters: Coralville, Iowa, USA
Cellular Engineering Technologies Inc. (CET) is a biotechnology company that develops and manufactures human stem cell-derived models for research, drug discovery, and regenerative medicine. CET specializes in non-immortalized human cells and stem cell lines designed to be physiologically relevant and free of genetic manipulation. The company’s portfolio includes stem cell-derived retinal cells, neurons, and hepatocytes for use in toxicology and disease modeling. CET places strong emphasis on ethically sourced cells and xeno-free, GMP-compliant manufacturing. The company collaborates with research institutions and pharmaceutical companies globally to accelerate safe and effective therapeutic development through advanced in vitro human cell models.
4. CellGenix GmbH
Headquarters: Freiburg, Germany
CellGenix GmbH is a leading developer and manufacturer of high-quality reagents and raw materials for cell and gene therapy and regenerative medicine. The company offers GMP-grade cytokines, media, and other components critical for the safe and efficient expansion of stem cells and immune cells in clinical applications. With decades of experience in GMP production, CellGenix supports biopharma companies and research institutions in developing advanced therapies. The firm places emphasis on regulatory compliance, product consistency, and traceability, helping clients meet stringent standards. CellGenix is recognized for its innovation in cell processing solutions and its commitment to advancing cellular therapies globally.
5. PromoCell GmbH
Headquarters: Heidelberg, Germany
PromoCell GmbH is a German biotechnology company that supplies primary human cells, stem cells, and optimized cell culture media for academic, clinical, and industrial applications. Their product portfolio includes human mesenchymal stem cells, hematopoietic stem cells, and endothelial progenitor cells, used widely in research, drug testing, and tissue engineering. PromoCell is known for its high-quality, ethically sourced cells and its user-friendly, serum-free media formulations that ensure reproducibility and scalability. The company also provides technical support and training to researchers worldwide. PromoCell’s commitment to scientific excellence and customer-centric solutions positions it as a trusted partner in regenerative medicine and life sciences.
Are you ready to discover more about the stem cell therapy market?
The report provides an in-depth analysis of the leading companies operating in the global stem cell therapy market. It includes a comparative assessment based on their product portfolios, business overviews, geographical footprint, strategic initiatives, market segment share, and SWOT analysis. Each company is profiled using a standardized format that includes:
Company Profiles
- Advanced Cell Technology Inc.
- Business Overview
- Company Snapshot
- Products Overview
- Company Market Share Analysis
- Company Coverage Portfolio
- Financial Analysis
- Recent Developments
- Merger and Acquisitions
- SWOT Analysis
- STEMCELL Technologies Inc.
- Cellular Engineering Technologies Inc.
- CellGenix GmbH
- PromoCell GmbH
- Kite Pharma
- Lonza
- Cellartis AB
- Angel Biotechnology
- Brainstorm Cell Therapeutics
- Celgene Corporation
- Osiris Therapeutics
- Genea Biocells
- Bioheart Inc.
- Waisman Biomanufacturing
- Tigenix
- Caladrius Biosciences
- Gamida Cell
Conclusion
The stem cell therapy market is rapidly emerging as a transformative force in modern medicine, offering new hope for treating chronic, degenerative, and previously incurable conditions. Driven by significant advancements in biotechnology, supportive regulatory frameworks, and expanding clinical applications, the sector is witnessing increased investments and research activities globally. The growing demand for personalized medicine and regenerative solutions is fostering innovation and collaboration across academia, biotech firms, and healthcare institutions. As stem cell therapies continue to evolve and prove their efficacy and safety, the market is set to reshape the healthcare landscape, opening doors to more targeted, effective, and sustainable treatments.
About the Spherical Insights & Consulting
Spherical Insights & Consulting is a market research and consulting firm which provides actionable market research study, quantitative forecasting and trends analysis provides forward-looking insight especially designed for decision makers and aids ROI.
Which is catering to different industry such as financial sectors, industrial sectors, government organizations, universities, non-profits and corporations. The company's mission is to work with businesses to achieve business objectives and maintain strategic improvements.
CONTACT US:
For More Information on Your Target Market, Please Contact Us Below:
Phone: +1 303 800 4326 (the U.S.)
Phone: +91 90289 24100 (APAC)
Email: inquiry@sphericalinsights.com, sales@sphericalinsights.com
Contact Us: https://www.sphericalinsights.com/contact-us
Need help to buy this report?